“irritable-bowel-syndrome” Archives

Entry Author Date Location
Synergy Hits Mark on Second Trial, Eyes Approval For Constipation Drug 07/30/15 New York
Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease 07/16/15 San Francisco
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs 05/22/13 Boston
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts 05/06/13 San Diego
Ironwood Pharmaceuticals Wins FDA Approval For Constipation Drug 08/30/12 Boston
Ardelyx Nabs $30M To Develop Drug for Irritable Bowel Syndrome, and High Blood Pressure 08/31/11 San Francisco
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Ironwood, Forest Seek FDA Approval 08/09/11 Boston
Tioga Drug Gets Fast Track Status 06/06/11 San Diego
Ironwood, One of the Big Boys Now, Strikes Deal With Tiny Protagonist Therapeutics 01/18/11 Boston
Ironwood Passes 4th Big Trial 11/01/10 Boston
Ironwood Pharmaceuticals Sells Struggling Microbia Subsidiary to Royal DSM 09/22/10 Boston
Ironwood Pharma Passes Third Big Clinical Trial With Constipation Drug, Shares Climb 09/13/10 Boston
Ironwood Pharma CEO Peter Hecht Breaks Silence on Company’s Big Biotech IPO 03/23/10 Boston
Another Setback for Cadence, Stimulus Funds Help Fuel Life Sciences Jobs, Tioga Gets More Funding for Drug Trial & More San Diego Life Sciences News 02/18/10 San Diego
San Diego’s Tioga Pharmaceuticals Raises $18 Million to Develop IBS Drug 02/17/10 San Diego
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry 02/01/10 Boston
Ironwood Gets $75M Deal From Astellas to Market Bowel Drug in Asia 11/10/09 Boston
Reality is Virtual at San Diego’s Tioga Pharmaceuticals 09/11/09 San Diego
Ironwood Gets $40M From European Partner for Constipation Drug 05/04/09 Boston
Page 1 of 1